{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T20:50:26Z","timestamp":1791579026838,"version":"4.3.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Fear of cancer recurrence (FCR) is pervasive among cancer survivors, yet evidence-based care is rarely implemented. Clinical pathways offer a structured approach to translating evidence into practice. This study identified key implementation barriers, enablers, and strategies for feasibly integrating an FCR clinical pathway comprising screening, assessment, and triage to stepped care into practice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A three-round Delphi study was conducted with Australian health professionals and FCR researchers. Participants rated and provided qualitative feedback on the feasibility of FCR clinical pathway elements. Qualitative responses were content analysed using the updated Consolidated Framework for Implementation Research. Recommended strategies were mapped using the Expert Recommendations for Implementing Change taxonomy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Eighty-nine participants completed Round 1, 69 Round 2, and 73 Round 3. Feasibility ratings varied across pathway elements (49\u201390%). Stepped care elements were widely endorsed as feasible (71-83% agreement), while resource-intensive recommendations (e.g., training all staff for screening) were perceived as least feasible. Key implementation enablers included Adaptability, Access to Knowledge and Information, and strong Innovation Recipient Need. Major barriers were Available Resources, Work Infrastructure and limited Innovation Deliverer Opportunity. Recommended strategies included tailoring delivery to local contexts and patient needs supported by modular training and local champions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Implementing the FCR clinical pathway requires pragmatic adaptation and system-level support. Prioritising high-impact elements, providing training, integration into existing workflows, and shared decision-making to meet patient needs are critical. Future research should evaluate these strategies using hybrid effectiveness\u2013implementation designs to ensure sustainable implementation and improved patient outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00520-026-11275-9","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T07:26:15Z","timestamp":1791530775000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Designing for delivery: a Delphi study of feasibility-informed implementation strategies for a fear of cancer recurrence clinical pathway"],"prefix":"10.1007","volume":"34","author":[{"given":"Ben","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verena Shuwen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Pearce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather L.","family":"Shepherd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afaf","family":"Girgis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gail","family":"Garvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Kirsten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iman","family":"Zakhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Ee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Ewald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agamjot Kaur","family":"Virk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joy","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,9]]},"reference":[{"key":"11275_CR1","unstructured":"Ferlay J, E.M., Lam F, Laversanne M, Colombet M, Mery L, Pi\u00f1eros M, Znaor A, Soerjomataram I, Bray F (2024) Global cancer observatory: cancer today (version 1.1).\u00a0 Available from: https:\/\/gco.iarc.who.int\/today. Accessed 08\/01\/2026"},{"issue":"8","key":"11275_CR2","doi-asserted-by":"publisher","first-page":"3265","DOI":"10.1007\/s00520-016-3272-5","volume":"24","author":"S Lebel","year":"2016","unstructured":"Lebel S et al (2016) From normal response to clinical problem: definition and clinical features of fear of cancer recurrence. Support Care Cancer 24(8):3265\u20133268","journal-title":"Support Care Cancer"},{"issue":"6","key":"11275_CR3","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1002\/pon.5921","volume":"31","author":"YL Luigjes-Huizer","year":"2022","unstructured":"Luigjes-Huizer YL et al (2022) What is the prevalence of fear of cancer recurrence in cancer survivors and patients? A systematic review and individual participant data meta-analysis. Psychooncology 31(6):879\u2013892","journal-title":"Psychooncology"},{"issue":"2","key":"11275_CR4","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1002\/pon.5283","volume":"29","author":"B Mutsaers","year":"2020","unstructured":"Mutsaers B et al (2020) Identifying the key characteristics of clinical fear of cancer recurrence: an international Delphi study. Psychooncology 29(2):430\u2013436","journal-title":"Psychooncology"},{"issue":"3","key":"11275_CR5","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1007\/s11764-013-0272-z","volume":"7","author":"S Simard","year":"2013","unstructured":"Simard S et al (2013) Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies. J Cancer Surviv 7(3):300\u2013322","journal-title":"J Cancer Surviv"},{"issue":"8","key":"11275_CR6","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1002\/pon.5673","volume":"30","author":"JTW Williams","year":"2021","unstructured":"Williams JTW, Pearce A, Smith AB (2021) A systematic review of fear of cancer recurrence related healthcare use and intervention cost-effectiveness. Psychooncology 30(8):1185\u20131195","journal-title":"Psychooncology"},{"key":"11275_CR7","doi-asserted-by":"publisher","DOI":"10.1111\/ajco.13176","author":"K Lisy","year":"2019","unstructured":"Lisy K et al (2019) Identifying the most prevalent unmet needs of cancer survivors in Australia: a systematic review. Asia Pac J Clin Oncol. https:\/\/doi.org\/10.1111\/ajco.13176","journal-title":"Asia Pac J Clin Oncol"},{"issue":"3","key":"11275_CR8","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s00520-008-0444-y","volume":"17","author":"S Simard","year":"2009","unstructured":"Simard S, Savard J (2009) Fear of Cancer Recurrence Inventory: development and initial validation of a multidimensional measure of fear of cancer recurrence. Support Care Cancer 17(3):241\u2013251","journal-title":"Support Care Cancer"},{"issue":"1","key":"11275_CR9","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12955-018-0850-x","volume":"16","author":"GM Humphris","year":"2018","unstructured":"Humphris GM et al (2018) Unidimensional scales for fears of cancer recurrence and their psychometric properties: the FCR4 and FCR7. Health Qual Life Outcomes 16(1):30","journal-title":"Health Qual Life Outcomes"},{"issue":"6","key":"11275_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/pon.6364","volume":"33","author":"L Gigu\u00e8re","year":"2024","unstructured":"Gigu\u00e8re L et al (2024) The Ottawa clinical fear of recurrence instruments: a screener, self-report, and clinical interview. Psychooncology 33(6):e6364","journal-title":"Psychooncology"},{"issue":"36","key":"11275_CR11","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1200\/JCO.2017.73.1257","volume":"35","author":"PN Butow","year":"2017","unstructured":"Butow PN et al (2017) Randomized trial of ConquerFear: a novel, theoretically based psychosocial intervention for fear of cancer recurrence. J Clin Oncol 35(36):4066\u20134077","journal-title":"J Clin Oncol"},{"issue":"3","key":"11275_CR12","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1037\/hea0001253","volume":"42","author":"C Maheu","year":"2023","unstructured":"Maheu C et al (2023) Fear of cancer recurrence therapy (FORT): a randomized controlled trial. Health Psychol 42(3):182\u2013194","journal-title":"Health Psychol"},{"issue":"19","key":"11275_CR13","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1200\/JCO.2016.70.5301","volume":"35","author":"M van de Wal","year":"2017","unstructured":"van de Wal M et al (2017) Efficacy of blended cognitive behavior therapy for high fear of recurrence in breast, prostate, and colorectal cancer survivors: the SWORD study, a randomized controlled trial. J Clin Oncol 35(19):2173\u20132183","journal-title":"J Clin Oncol"},{"key":"11275_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare13172165","author":"C Maheu","year":"2025","unstructured":"Maheu C et al (2025) Systematic review of fear of cancer recurrence patient-reported outcome measures: evaluating methodological quality and measurement properties using the COSMIN checklist. Healthcare (Basel). https:\/\/doi.org\/10.3390\/healthcare13172165","journal-title":"Healthcare (Basel)"},{"issue":"31","key":"11275_CR15","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1200\/JCO.19.00572","volume":"37","author":"NM Tauber","year":"2019","unstructured":"Tauber NM et al (2019) Effect of psychological intervention on fear of cancer recurrence: a systematic review and meta-analysis. J Clin Oncol 37(31):2899\u20132915","journal-title":"J Clin Oncol"},{"issue":"4","key":"11275_CR16","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1007\/s11764-022-01285-x","volume":"17","author":"E Deuning-Smit","year":"2023","unstructured":"Deuning-Smit E et al (2023) Barriers and facilitators for implementation of the SWORD evidence-based psychological intervention for fear of cancer recurrence in three different healthcare settings. J Cancer Surviv 17(4):1057\u20131071","journal-title":"J Cancer Surviv"},{"issue":"10","key":"11275_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/pon.70293","volume":"34","author":"S Lebel","year":"2025","unstructured":"Lebel S et al (2025) Investigating the pre-implementation facilitators and barriers of the implementation of the Fear of Recurrence Therapy (FORT) intervention in Canadian cancer centers. Psychooncology 34(10):e70293","journal-title":"Psychooncology"},{"key":"11275_CR18","unstructured":"Lebel S, Zwaal C, Craig L, Conrod R, Freeman L, Galica J, Maheu C, Nissim R, Savard J et al (2024) Fear of cancer recurrence guideline. Toronto (ON): Ontario Health (Cancer Care Ontario). Program in Evidence-Based Care Guideline No.: 19\u20137"},{"key":"11275_CR19","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1007\/s11764-024-01685-1","volume":"20","author":"AB Smith","year":"2026","unstructured":"Smith AB, Girgis A, Taylor N et al (2026) Step-by-step: A clinical pathway for stepped care management of fear of cancer recurrence\u2014results of a three-round online delphi consensus process with Australian health professionals and researchers. J Cancer Surviv 20:766\u2013780. https:\/\/doi.org\/10.1007\/s11764-024-01685-1","journal-title":"J Cancer Surviv"},{"issue":"2","key":"11275_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/pon.70070","volume":"34","author":"MJ Tran","year":"2025","unstructured":"Tran MJ et al (2025) Feasibility and acceptability of the fear-less screening and stratified-care model for fear of cancer recurrence among people affected by early-stage cancer. Psychooncology 34(2):e70070","journal-title":"Psychooncology"},{"key":"11275_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2021.596682","volume":"12","author":"J Shaw","year":"2021","unstructured":"Shaw J et al (2021) Setting an international research agenda for fear of cancer recurrence: an online Delphi consensus study. Front Psychol 12:596682","journal-title":"Front Psychol"},{"issue":"1","key":"11275_CR22","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12961-022-00815-4","volume":"20","author":"VC Pereira","year":"2022","unstructured":"Pereira VC et al (2022) Strategies for the implementation of clinical practice guidelines in public health: an overview of systematic reviews. Health Res Policy Syst 20(1):13","journal-title":"Health Res Policy Syst"},{"issue":"8","key":"11275_CR23","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1177\/0269216317690685","volume":"31","author":"S J\u00fcnger","year":"2017","unstructured":"J\u00fcnger S et al (2017) Guidance on conducting and reporting Delphi studies (CREDES) in palliative care: recommendations based on a methodological systematic review. Palliat Med 31(8):684\u2013706","journal-title":"Palliat Med"},{"key":"11275_CR24","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i6795","volume":"356","author":"H Pinnock","year":"2017","unstructured":"Pinnock H et al (2017) Standards for reporting implementation studies (StaRI) statement. BMJ 356:i6795","journal-title":"BMJ"},{"issue":"1","key":"11275_CR25","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13012-022-01245-0","volume":"17","author":"LJ Damschroder","year":"2022","unstructured":"Damschroder LJ et al (2022) The updated consolidated framework for implementation research based on user feedback. Implement Sci 17(1):75","journal-title":"Implement Sci"},{"issue":"1","key":"11275_CR26","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13012-019-0876-4","volume":"14","author":"CK Perry","year":"2019","unstructured":"Perry CK et al (2019) Specifying and comparing implementation strategies across seven large implementation interventions: a practical application of theory. Implement Sci 14(1):32","journal-title":"Implement Sci"},{"issue":"1","key":"11275_CR27","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13012-015-0209-1","volume":"10","author":"BJ Powell","year":"2015","unstructured":"Powell BJ et al (2015) A refined compilation of implementation strategies: results from the Expert Recommendations for Implementing Change (ERIC) project. Implement Sci 10(1):21","journal-title":"Implement Sci"},{"key":"11275_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-015-0691-9","author":"NM Rankin","year":"2015","unstructured":"Rankin NM et al (2015) Everybody wants it done but nobody wants to do it: an exploration of the barrier and enablers of critical components towards creating a clinical pathway for anxiety and depression in cancer. BMC Health Serv Res. https:\/\/doi.org\/10.1186\/s12913-015-0691-9","journal-title":"BMC Health Serv Res"},{"issue":"6","key":"11275_CR29","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1002\/pon.6139","volume":"32","author":"AB Smith","year":"2023","unstructured":"Smith AB et al (2023) Evaluation of the validity and screening performance of a revised single-item fear of cancer recurrence screening measure (FCR-1r). Psychooncology 32(6):961\u2013971","journal-title":"Psychooncology"},{"key":"11275_CR30","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s41687-018-0061-6","volume":"2","author":"J Greenhalgh","year":"2018","unstructured":"Greenhalgh J et al (2018) How do patient reported outcome measures (PROMs) support clinician-patient communication and patient care? A realist synthesis. J Patient Rep Outcomes 2:42","journal-title":"J Patient Rep Outcomes"},{"key":"11275_CR31","doi-asserted-by":"publisher","DOI":"10.1200\/op.20.00799","author":"J Liu","year":"2021","unstructured":"Liu J et al (2021) Novel clinician-lead intervention to address fear of cancer recurrence in breast cancer survivors. JCO Oncol Pract. https:\/\/doi.org\/10.1200\/op.20.00799","journal-title":"JCO Oncol Pract"},{"key":"11275_CR32","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djaf153","author":"T Abdalla","year":"2025","unstructured":"Abdalla T et al (2025) Stepped-care models for cancer symptom management: a systematic review of efficacy and cost-effectiveness. JNCI J Natl Cancer Inst. https:\/\/doi.org\/10.1093\/jnci\/djaf153","journal-title":"JNCI J Natl Cancer Inst"},{"issue":"2","key":"11275_CR33","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1001\/jamapsychiatry.2021.3539","volume":"79","author":"J Delgadillo","year":"2022","unstructured":"Delgadillo J et al (2022) Stratified care vs stepped care for depression: a cluster randomized clinical trial. JAMA Psychiat 79(2):101\u2013108","journal-title":"JAMA Psychiat"},{"key":"11275_CR34","doi-asserted-by":"publisher","DOI":"10.1177\/16094069251340908","volume":"24","author":"N Taylor","year":"2025","unstructured":"Taylor N et al (2025) Advancing the speed and science of implementation using mixed-methods process mapping \u2013 best practice recommendations. Int J Qual Methods 24:16094069251340908","journal-title":"Int J Qual Methods"},{"issue":"1","key":"11275_CR35","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s43058-024-00654-0","volume":"5","author":"J Lyu","year":"2024","unstructured":"Lyu J et al (2024) Facilitators and barriers to implementing patient-reported outcomes in clinical oncology practice: a systematic review based on the consolidated framework for implementation research. Implement Sci Commun 5(1):120","journal-title":"Implement Sci Commun"},{"issue":"4","key":"11275_CR36","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1002\/pon.3423","volume":"23","author":"B Thewes","year":"2014","unstructured":"Thewes B et al (2014) Current approaches to managing fear of cancer recurrence; a descriptive survey of psychosocial and clinical health professionals. Psychooncology 23(4):390\u2013396","journal-title":"Psychooncology"},{"issue":"3","key":"11275_CR37","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s13187-018-1331-y","volume":"34","author":"J Berrett-Abebe","year":"2019","unstructured":"Berrett-Abebe J et al (2019) Impact of an interprofessional primary care training on fear of cancer recurrence on clinicians\u2019 knowledge, self-efficacy, anticipated practice behaviors, and attitudes toward survivorship care. J Cancer Educ 34(3):505\u2013511","journal-title":"J Cancer Educ"},{"issue":"1","key":"11275_CR38","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12913-022-07521-5","volume":"22","author":"J Shaw","year":"2022","unstructured":"Shaw J et al (2022) Development, acceptability and uptake of an on-line communication skills education program targeting challenging conversations for oncology health professionals related to identifying and responding to anxiety and depression. BMC Health Serv Res 22(1):132","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"11275_CR39","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13012-020-01024-9","volume":"15","author":"K Bonawitz","year":"2020","unstructured":"Bonawitz K et al (2020) Champions in context: which attributes matter for change efforts in healthcare? Implement Sci 15(1):62","journal-title":"Implement Sci"},{"key":"11275_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2021.621850","author":"K Anderson","year":"2021","unstructured":"Anderson K et al (2021) A systematic review of fear of cancer recurrence among indigenous and minority peoples. Front Psychol. https:\/\/doi.org\/10.3389\/fpsyg.2021.621850","journal-title":"Front Psychol"},{"issue":"6","key":"11275_CR41","first-page":"565","volume":"73","author":"RJ Chan","year":"2023","unstructured":"Chan RJ et al (2023) Patient navigation across the cancer care continuum: an overview of systematic reviews and emerging literature. CA Cancer J Clin 73(6):565\u2013589","journal-title":"CA Cancer J Clin"},{"key":"11275_CR42","doi-asserted-by":"publisher","DOI":"10.1097\/OR9.0000000000000061","author":"PN Butow","year":"2021","unstructured":"Butow PN et al (2021) From ideal to actual practice: tailoring a clinical pathway to address anxiety or depression in patients with cancer and planning its implementation across individual clinical services. J Psychosoc Oncol Res Pract. https:\/\/doi.org\/10.1097\/OR9.0000000000000061","journal-title":"J Psychosoc Oncol Res Pract"},{"issue":"5","key":"11275_CR43","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1093\/jnci\/djaa083","volume":"113","author":"D Howell","year":"2021","unstructured":"Howell D et al (2021) Management of cancer and health after the clinic visit: a call to action for self-management in cancer care. J Natl Cancer Inst 113(5):523\u2013531","journal-title":"J Natl Cancer Inst"},{"key":"11275_CR44","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1007\/s11764-022-01326-5","volume":"18","author":"YL Luigjes-Huizer","year":"2024","unstructured":"Luigjes-Huizer YL, van der Lee ML, Richel C et al (2024) Patient-reported needs for coping with worry or fear about cancer recurrence and the extent to which they are being met: a survey study. J Cancer Surviv 18:791\u2013799. https:\/\/doi.org\/10.1007\/s11764-022-01326-5","journal-title":"J Cancer Surviv"},{"issue":"1","key":"11275_CR45","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s13012-018-0832-8","volume":"13","author":"M Jabbour","year":"2018","unstructured":"Jabbour M et al (2018) Defining barriers and enablers for clinical pathway implementation in complex clinical settings. Implement Sci 13(1):139","journal-title":"Implement Sci"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-11275-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-11275-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-11275-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T20:03:31Z","timestamp":1791576211000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-026-11275-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,9]]},"references-count":45,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["11275"],"URL":"https:\/\/doi.org\/10.1007\/s00520-026-11275-9","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,9]]},"assertion":[{"value":"16 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the University of New South Wales Human Research Ethics Committee (HC230052).","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ben Smith has received honorarium from Novartis to participate in a podcast on fear of cancer recurrence. Andrea Smith sits on Patient Advisory Groups for Menarini Stemline and Gilead and has received travel funding and honorarium payments. No other authors have any other conflicts of interest to declare.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1079"}}